IN-VIVO BINDING OF [I-125] NH2-CARFENTANIL TO MU-OPIOID RECEPTORS IN MOUSE-BRAIN

Citation
Jam. Tafani et al., IN-VIVO BINDING OF [I-125] NH2-CARFENTANIL TO MU-OPIOID RECEPTORS IN MOUSE-BRAIN, Nuclear medicine and biology, 21(2), 1994, pp. 231-238
Citations number
37
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
Nuclear medicine and biology
ISSN journal
09698051 → ACNP
Volume
21
Issue
2
Year of publication
1994
Pages
231 - 238
Database
ISI
SICI code
0969-8051(1994)21:2<231:IBO[NT>2.0.ZU;2-6
Abstract
A functionalized derivative of the mu opioid agonist carfentanil was s ynthesized (NH2-carfentanil) and showed high specific activity when ra diolabeled with iodine. [I-127]NH2-carfentanil displayed high affinity and pronounced mu-binding selectivity with a delta/mu selectivity rat io of over 1200. The ability of [I-125]NH2- carfentanil to interact in vivo with opioid receptors was determined in mouse brain using ex viv o binding techniques. Twenty minutes after intraperitoneal injection, 0.1% of the [I-125]NH2-carfentanil injected into the mouse was present in the brain. [I-125]NH2-carfentanil specific binding was inhibited b y co-injection of naloxone or morphine while naltrindole, a delta-sele ctive antagonist, was unable to displace the bound radioligand. Autora diographic experiments revealed a heterogeneous distribution of [I-125 ]NH2-carfentanil specific binding sites, maximal binding occurred in a reas with high densities of mu receptors. Peripherally administered io do-NH2-carfentanil selectively labelled central mu opioid receptors in mouse indicating great potential for single photon emission computed tomography studies.